Your browser doesn't support javascript.
loading
Efficacy of Etanercept in the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Dreyer, Sean David; Torres, Juan; Stoddard, Marie; Leavitt, Erica; Sutton, Adam; Aleshin, Maria; Crew, Ashley; Worswick, Scott.
Afiliação
  • Dreyer SD; Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebras
  • Torres J; Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebras
  • Stoddard M; Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebras
  • Leavitt E; Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebras
  • Sutton A; Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebras
  • Aleshin M; Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebras
  • Crew A; Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebras
  • Worswick S; Drs. Dreyer, Torres, and Leavitt are from the Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles. Dr. Stoddard is from the Department of Dermatology, University of Michigan, Ann Arbor. Dr. Sutton is from the Department of Dermatology, University of Nebras
Cutis ; 107(6): E22-E28, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34314327
ABSTRACT
It has been suggested that the use of etanercept for treatment of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) might provide improved mortality benefit and decreased skin healing times. This retrospective study compared the use of single-dose subcutaneous etanercept to intravenous immunoglobulin (IVIG) and supportive care alone. Thirteen patients were treated with a single dose (50 mg) of subcutaneous etanercept. Results of this study support the use of etanercept as a potentially beneficial agent in the treatment of SJS/TEN.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Stevens-Johnson Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Stevens-Johnson Idioma: En Ano de publicação: 2021 Tipo de documento: Article